Case Report: Breast ductal carcinoma in situ with microinvasion: a case tracked over 13 years
Open Access
- 12 August 2025
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1560366
Abstract
Background: Numerous studies have reported considerable heterogeneity in breast ductal carcinoma in situ with microinvasion (DCIS-MI) regarding clinical presentation, progression potential, and treatment strategies.Case presentation: In this work, we report a case of rapidly progressing multiple metastases in a patient with DCIS-MI following conventional treatment. Subsequent fluorescence in situ hybridization (FISH) testing revealed HER2 gene overexpression. After receiving 10 cycles of trastuzumab-targeted therapy, the patient achieved a favorable prognosis and remains stable to date.Conclusion: This case suggests that even patients with microinvasive lesions who are HER2-positive may exhibit unexpected stability under targeted therapy, warranting close surveillance in such cases.Keywords
This publication has 36 references indexed in Scilit:
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCISJNCI: Journal of the National Cancer Institute, 2011
- Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic ReviewJournal of Cancer, 2011
- Breast cancer precursors revisited: molecular features and progression pathwaysHistopathology, 2010
- Microinvasive ductal carcinoma in situ: Clinical presentation, imaging features, pathologic findings, and outcomeEuropean Journal of Radiology, 2010
- Meta-analysis of sentinel node biopsy in ductal carcinomain situof the breastBritish Journal of Surgery, 2008
- Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesAnnals of Oncology, 2004
- Breast ductal carcinoma in situ with microinvasionCancer, 2002
- In vivo cell kinetics in breast carcinogenesis2001
- Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal‐deoxynucleotidyl‐transferase‐mediated dUTP‐FITC nick end labelling (TUNEL)Histopathology, 1997
- Extensive apoptosis in ductal carcinoma in situ of the breastCancer, 1996